FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to a complex for the antimicrobial and / or anti-inflammatory action, which contains fulvic acid having a molecular weight not exceeding 20 kDa herewith fulvic acid derived from sugar. The complex can also contains aluminum, mercury, cadmium, chromium and lead in amounts which do not harm human body. The invention also relates to a method of producing the specified complex which comprises dissolving the carbohydrate to form of a solution and oxidation of this carbohydrate in the water vapor. The obtained product, containing acidic components is subjected to filtration to remove acidic components with a molecular mass greater than 20 kDa.
EFFECT: invention provides complexes of fulvic acid, which practically does not contain harmful elements such as aluminum, chromium, mercury, other, and can be safely used in the pharmaceutical industry.
26 cl, 2 dwg, 1 tbl, 4, ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION CONTAINING FULVIC ACID AND ANTIBIOTICS | 2009 |
|
RU2505295C2 |
| NON-ALCOHOLIC BEVERAGE WITH BIOPROTECTIVE AND ENERGY STIMULATING PROPERTIES | 2022 |
|
RU2806594C2 |
| SIZING COMPOSITION FOR FIBERS, NAMELY FOR MINERAL FIBERS BASED ON HUMIC AND/OR FULVIC ACID AND OBTAINED INSULATION PRODUCTS | 2013 |
|
RU2621243C2 |
| COMBINATION OF FULVIC ACID FOR TREATMENT OF VARIOUS CONDITIONS AND DISEASES | 2010 |
|
RU2535037C2 |
| BIOLOGICALLY ACTIVE SUBSTANCE COMPOSITION | 2021 |
|
RU2792886C1 |
| COMPOSITIONS AND METHODS FOR REMOVING HYDROGEN SULFIDE AND OTHER CONTAMINANTS FROM LIQUIDS BASED ON HYDROCARBONS AND AQUEOUS SOLUTIONS | 2018 |
|
RU2791535C2 |
| PASTA | 2022 |
|
RU2813325C1 |
| ANTIMICROBIAL COMPOSITION BASED ON POLYPHENOLS AND POLYSACCHARIDES, METHOD FOR ITS PREPARATION AND APPLICATION | 2018 |
|
RU2754067C2 |
| METHOD OF OBTAINING A LOW-MINERALISED PREPARATION BASED ON FULVIC ACIDS OF PELOIDS | 2017 |
|
RU2663570C1 |
| COMBINATION OF FULVIC ACID AND ANTIBIOTIC FOR SUPPRESSION OF GROWTH OF BACTERIA RESISTANT TO MAJORITY OF DRUGS, OR TREATMENT OF INFECTIONS CAUSED BY THEM | 2013 |
|
RU2640928C2 |
